AnteoTechAnteoTechAnteoTechAnteoTech
  • Home
  • About
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
    • ADVISORY BOARDS
  • Life Science
    • ANTEOBIND
      • ANTEOBIND PUBLICATIONS
    • PRODUCTS
    • CONTRACT SERVICES
    • CASE STUDIES
    • WEBINARS
  • Energy
    • WEBINARS
  • EuGeni
  • Newsroom
  • Investors
    • 2021 ANNUAL GENERAL MEETING
    • ASX ANNOUNCEMENTS
    • CORPORATE GOVERNANCE & COMPANY POLICY
    • VIEW ON ASX
  • Customer Login
  • Contact

Test Platform and COVID-19 Test receive CE Mark approval

    Home announcements Test Platform and COVID-19 Test receive CE Mark approval
    NextPrevious

    Test Platform and COVID-19 Test receive CE Mark approval

    By AnteoTech | 2021 Announcements | Comments are Closed | 12 April, 2021 |

    AnteoTech Ltd is pleased to advise that it has received Conformitè Europëenne (CE) Mark registration for its EuGeni Reader and the in vitro rapid diagnostic test for the detection of SARS-CoV-2 nucleocapsid antigen, the COVID-19 ART.

    20210412 Test Platform and COVID-19 Test receive CE Mark approval
    No tags.

    NextPrevious

    Quick Links

    • About
    • Life Science
    • Energy
    • Investors
    • Customer Login

    Investors

    • ASX Announcements
    • Corporate Governance & Company Policy
    • Financial Reporting
    • Share Price Information

    Contact Us

    If you have any general questions about our products or technology, contact customer support on (07) 3219 0085 or email contact@anteotech.com. For all technical support, please email support@anteotech.com.

    For all investor-related queries please email investors@anteotech.com.

    Copyright © AnteoTech 2021. All rights reserved. AnteoCoat/AnteoBind are trademarks of the AnteoTech group of companies. All other trademarks referenced are owned by their respective companies.
    Website by Start Digital
    • Home
    • About
      • MANAGEMENT TEAM
      • BOARD OF DIRECTORS
      • ADVISORY BOARDS
    • Life Science
      • ANTEOBIND
        • ANTEOBIND PUBLICATIONS
      • PRODUCTS
      • CONTRACT SERVICES
      • CASE STUDIES
      • WEBINARS
    • Energy
      • WEBINARS
    • EuGeni
    • Newsroom
    • Investors
      • 2021 ANNUAL GENERAL MEETING
      • ASX ANNOUNCEMENTS
      • CORPORATE GOVERNANCE & COMPANY POLICY
      • VIEW ON ASX
    • Customer Login
    • Contact
    AnteoTech